Jan 11th: Keith March – Inventions at the Bedside
Join in a discussion around strategies to develop inventions in a clinical setting that can change healthcare while creating commercializable technologies. Dr. March will also speak about his experiences as a internationally recognized researcher, and inventor.
IU School of Medicine
Professor of Medicine; Cryptic Masons Medical Research Foundation Prof
This event is at Riley Hospital at the IU Medical Center. There is an attached parking garage just south of the building. After exiting the parking structure at ground level on the north side (past the elevators), entering the main hallway, there is a stairway down about 100 feet on the left hand side (a protective gate is at the top) to the auditorium. This stairway is past the information desk.
Keith L. March, MD, PhD
§ Professor, Departments of Medicine, Cellular and Integrative Physiology, and Biomedical Engineering, Indiana University School of Medicine and the Krannert Institute of Cardiology
§ Director, Indiana Center for Vascular Biology & Medicine (ICVBM)
§ Director, IUPUI Vascular and Cardiac Center of Adult Stem Cell Therapy (VC-CAST)
§ Director, VA Center for Regenerative Medicine
Keith March has dedicated his career to bringing new medical approaches to patients. His publications include more than 100 manuscripts. He was the editor of the first book dedicated to cardiovascular gene transfer. Dr. March’s research has resulted in more than 40 worldwide (19 U.S.) patents, with others pending. He invented the Closer, a widely-utilized patented suture-mediated closure device, used to close the puncture wound in an artery following heart catheterization. This device allows a patient to “walk off the table” after a catheterization without requiring prolonged bedrest. Abbott Vascular, an affiliate of Abbott Laboratories, acquired the company that developed this technology in 1999 and the Closer approach is used annually worldwide in 500,000 patients. He has served as a scientific advisor to numerous pharmaceutical, biotechnology and medical device companies.
His laboratory focuses on vascular biology, with a particular emphasis on the function and translational study of CD34+ stem cells found in the adipose tissue, which his laboratory identified as peri-vascular cells with critical roles in vasculogenesis, angiogenesis, and adipose tissue regulation. Dr. March is recognized as a leading expert in the field of adult stem cell research, particularly that involving adipose-derived stromal stem cells. In 2008, he became chair of the NIH/NHLBI DSMB that oversees cell therapy trials in the areas of heart, lung, and blood diseases.
In addition to his research roles, Dr. March has served as the president (2007) of the International Federation of Adipose Therapeutics and Science (IFATS); and serves as the Chief Medical Advisor for the Cell Therapy Foundation. In both affiliations, he has worked to advance collaboration as well as awareness about the significance of adult stem cells.